OC
DSGN icon

Oppenheimer & Co’s Design Therapeutics DSGN Stock Holding History

Oppenheimer & Co’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
+32,087
New +$400K 0.01% 1287

Other funds holding DSGN

CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Oppenheimer & Co's DSGN Position: Q2 2026 in Review

Oppenheimer & Co opened a new position in Design Therapeutics (DSGN) in Q2 2026: 32,087 shares worth $464K. The stake represents 0.01% of the portfolio and ranks #1287 among its holdings.

23 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Oppenheimer & Co held 32,087 shares of Design Therapeutics worth $464K as of Q2 2026.
  • Design Therapeutics was a new Oppenheimer & Co position in Q2 2026.
  • Design Therapeutics made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1287 holding.
  • 23 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.